GERICARE SENNA SYRUP- sennosides liquid

GeriCare Senna Syrup by

Drug Labeling and Warnings

GeriCare Senna Syrup by is a Otc medication manufactured, distributed, or labeled by ATLANTIC BIOLOGICALS CORP.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Per teaspoonful-5mL

Sennosides - 8.8 mg

PURPOSE

Purpose

Laxative

INDICATIONS & USAGE

Uses

• relieves occasional constipation (irregularity)
• generally causes bowel movment in 6 to 12 hours

WARNINGS

Warnings

Do not use

• laxative products for longer than 1 week unless directed by a doctor

Ask a doctor or pharmacis before use if you have

• stomach pain
• nausea
• vomiting
• noticed a sudden changed in bowel movement that continues over a period of 2 weeks

Stope use and ask a doctor if

you have rectal bleeding or failure to have a bowel movemebt after use of laxative. They may indicate a serious condition.

PREGNANCY

If pregnant or breast-feeding ask a health professional before use

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control Center immediately

DOSAGE & ADMINISTRATION

• shake well before use
• Do not exceed recommended dose

Age	Starting Dose	Maximum dosage
Adults and children 12 years and older	2-3 teaspoonfuls once a day preferably at bedtime; increase as needed or as recommended by a doctor	3 teaspoons in the morning and 3 teaspoons at bedtime
Under 12 years of age	ask a doctor	ask a doctor

INACTIVE INGREDIENT

Inactive ingredients artificial and natural chocolate flavor, methylparaben, propylene glycol, propylparaben, purified water, and sucrose.

QUESTIONS

Questions or comments? 1-800-540-3765

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

GERICARE SENNA SYRUP 
sennosides liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 17856-0462(NDC:57896-462)
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)	SENNOSIDES	8.8 mg  in 5 mL

Inactive Ingredients
Ingredient Name	Strength
METHYLPARABEN (UNII: A2I8C7HI9T)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
PROPYLPARABEN (UNII: Z8IX2SC1OH)
WATER (UNII: 059QF0KO0R)
SUCRALOSE (UNII: 96K6UQ3ZD4)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 17856-0462-1	72 in 1 BOX, UNIT-DOSE	07/23/2019
1		10 mL in 1 CUP, UNIT-DOSE; Type 0: Not a Combination Product
2	NDC: 17856-0462-3	72 in 1 BOX, UNIT-DOSE	07/23/2019
2		5 mL in 1 CUP, UNIT-DOSE; Type 0: Not a Combination Product
3	NDC: 17856-0462-2	120 in 1 BOX, UNIT-DOSE	07/23/2019
3		2.5 mL in 1 SYRINGE; Type 0: Not a Combination Product
4	NDC: 17856-0462-4	48 in 1 BOX, UNIT-DOSE	07/23/2019
4		5 mL in 1 SYRINGE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part334	05/01/2019

Labeler - ATLANTIC BIOLOGICALS CORP. (047437707)

Establishment
Name	Address	ID/FEI	Business Operations
ATLANTIC BIOLOGICALS CORP.		047437707	relabel(17856-0462) , repack(17856-0462)